RAYDIAX - About the company
RAYDIAX is a series A company based in Magdeburg (Germany), founded in 2021 by Tim Pfeiffer, Robert Frysch, Thomas Hoffmann and Andre Mewes. It operates as a Developer of therapy-assist CT system for minimally invasive interventions. RAYDIAX has raised $8.4M in funding from Bmp Ventures and HTGF. The company has 130 active competitors, including 41 funded and 13 that have exited. Its top competitors include companies like Scholar Rock, Lucida Medical and SamanTree Medical.
Company Details
Developer of therapy-assist CT system for minimally invasive interventions. The company offers a CT-guided therapy device that uses a navigation system and a combination of 2D and 3D X-ray live imaging for minimally invasive tumor interventions.
- Website
- raydiax.com
- Email ID
- *****@raydiax.com
- Phone Number
- +49 **********
Key Metrics
Founded Year
2021
Location
Magdeburg, Germany
Stage
Series A
Total Funding
$8.4M in 3 rounds
Latest Funding Round
Investors
Ranked
10th among 130 active competitors
Employee Count
21 as on Jul 31, 2026
Similar Companies
Legal entities associated with RAYDIAX
RAYDIAX is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
RAYDIAX GmbH CIN: W1215_HRB31220 , Germany, Active | Apr 07, 2022 | - | - |
Sign up to download RAYDIAX's company profile
RAYDIAX's funding and investors
RAYDIAX has raised a total funding of $8.4M over 3 rounds. Its first funding round was on Oct 26, 2023. Its latest funding round was a Grant (prize money) round on Mar 03, 2026 for $*****. 2 investors participated in its latest round. RAYDIAX has 6 institutional investors.
Here is the list of recent funding rounds of RAYDIAX:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 03, 2026 | 6415807 | Grant (prize money) | 7751285 | 7070757 | 3278360 | 8633164 |
Mar 03, 2026 | 5534236 | Series A | 1970599 | 4159505 | 7177768 | |
Oct 26, 2023 | 1305556 | Seed | 1764810 | 3916100 |
View details of RAYDIAX's funding rounds and investors
RAYDIAX's founders and board of directors
Founder? Claim ProfileThe founders of RAYDIAX are Tim Pfeiffer, Robert Frysch, Thomas Hoffmann and Andre Mewes. Thomas Hoffmann is the CEO of RAYDIAX.
Here are the details of RAYDIAX's key team members:
- Tim Pfeiffer: Co-Founder of RAYDIAX. Contact Info: 1 email address
- Robert Frysch: Co-Founder of RAYDIAX. Contact Info: 1 email address
- Thomas Hoffmann: Co-Founder & CEO of RAYDIAX. Contact Info: 1 email address
- Andre Mewes: Co-Founder of RAYDIAX. Contact Info: 1 email address
View details of RAYDIAX's Founder profiles and Board Members
RAYDIAX's employee count trend
RAYDIAX has 21 employees as of Jul 26. Here is RAYDIAX's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
RAYDIAX's Competitors and alternates
Top competitors of RAYDIAX include Scholar Rock, Lucida Medical and SamanTree Medical. Here is the list of Top 10 competitors of RAYDIAX, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Scholar Rock 2012, Cambridge (United States), Public | Developer of Antibody-based drugs for the treatment of primary myopathies | $103M | 61/100 | |
2nd | Lucida Medical 2019, Cambridge (United Kingdom), Series A | Developer of MRI-based cancer screening technology using artificial intelligence (AI) | $11.5M | 58/100 | |
3rd | SamanTree Medical 2014, Lausanne (Switzerland), Series C | Developer of digital microscopy system for high-resolution imaging of tissue | $57.5M | 58/100 | |
4th | CurveBeam AI 2009, Melbourne (Australia), Public | Developer of AI-powered CT imaging solutions | $25.3M | 57/100 | |
5th | Developer of diagnostic instruments, reagents, and related software | - | - | 54/100 | |
6th | Koning 2002, United States, Funding Raised | Innovating breast imaging with advanced 3D CT technology | - | 54/100 | |
7th | Perfint Healthcare 2005, Chennai (India), Series D | Developer of solutions for image-guided interventional procedures | $41.5M | 54/100 | |
8th | MARS Bioimaging 2007, Christchurch (New Zealand), Series A | Spectral molecular imaging technology | $15.4M | 53/100 | |
9th | Ionpath 2014, Menlo Park (United States), Series B | Developer of an imaging platform for tissue biopsies | $18M | 53/100 | |
10th | Developer of therapy-assist CT system for minimally invasive interventions | $8.4M | 52/100 |
Looking for more details on RAYDIAX's competitors? Click here to see the top ones
RAYDIAX's Investments and acquisitions
RAYDIAX has made no investments or acquisitions yet.
Reports related to RAYDIAX
Here is the latest report on RAYDIAX's geography:
News related to RAYDIAX
Media has covered RAYDIAX for 1 event in last 1 year.
•
•
Raydiax Raises €3.5M in FundingFinSMEs•Oct 27, 2023•RAYDIAX, HTGF, Bmp Ventures, IB Global and 1 other
•
Are you a Founder ?
FAQs about RAYDIAX
Explore our recently published companies
- ReFrame Engage - United States based, 2020 founded, Unfunded company
- Web Instant Messenger - Bolzano based, 2016 founded, Unfunded company
- Carekro - 2018 founded, Unfunded company
- Dnyhospitality - Unfunded company
- Doral SEO - Doral based, 2026 founded, Unfunded company
- EMJ - Italy based, 2026 founded, Unfunded company
